Dr. Geoffrey Eubank, MD

Vascular Neurology Columbus, OH Male
NPI: 1992799167
Total Payments
$538,903
2024 Payments
$91,054
Companies
23
Transactions
734
Medicare Patients
1,734
Medicare Billing
$535,742

Payment Breakdown by Category

Other$394,064 (73.1%)
Consulting$80,803 (15.0%)
Travel$28,580 (5.3%)
Food & Beverage$26,343 (4.9%)
Research$8,956 (1.7%)
Education$157.71 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $383,414 159 71.1%
Consulting Fee $80,803 38 15.0%
Travel and Lodging $28,580 116 5.3%
Food and Beverage $26,343 398 4.9%
Honoraria $10,650 8 2.0%
Unspecified $8,956 12 1.7%
Education $157.71 3 0.0%

Payments by Type

General
$529,947
722 transactions
Research
$8,956
12 transactions

Top Paying Companies

Company Total Records Latest Year
EMD Serono, Inc. $113,275 215 $0 (2024)
Genentech USA, Inc. $94,968 89 $0 (2024)
Biogen, Inc. $85,786 143 $0 (2024)
GENZYME CORPORATION $65,630 70 $0 (2024)
TG Therapeutics, Inc. $50,662 41 $0 (2024)
E.R. Squibb & Sons, L.L.C. $28,892 25 $0 (2024)
Horizon Therapeutics plc $25,226 37 $0 (2023)
Novartis Pharmaceuticals Corporation $21,767 39 $0 (2024)
Celgene Corporation $13,253 26 $0 (2024)
Amgen Inc. $12,484 16 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $91,054 126 EMD Serono, Inc. ($34,240)
2023 $71,947 114 EMD Serono, Inc. ($21,311)
2022 $85,152 132 EMD Serono, Inc. ($24,202)
2021 $57,403 75 EMD Serono, Inc. ($15,889)
2020 $33,865 50 Biogen, Inc. ($16,419)
2019 $77,778 96 GENZYME CORPORATION ($21,027)
2018 $63,551 64 Genentech USA, Inc. ($20,440)
2017 $58,155 77 GENZYME CORPORATION ($12,862)

All Payment Transactions

734 individual payment records from CMS Open Payments — Page 1 of 30

Date Company Product Nature Form Amount Type
12/31/2024 EMD Serono, Inc. — Food and Beverage Cash or cash equivalent $62.12 General
12/12/2024 EMD Serono, Inc. Mavenclad (Drug) Food and Beverage Cash or cash equivalent $124.59 General
Category: Neurology
12/12/2024 EMD Serono, Inc. Mavenclad (Drug) Travel and Lodging Cash or cash equivalent $107.00 General
Category: Neurology
12/12/2024 EMD Serono, Inc. Mavenclad (Drug) Travel and Lodging Cash or cash equivalent $41.70 General
Category: Neurology
12/12/2024 EMD Serono, Inc. Mavenclad (Drug) Travel and Lodging Cash or cash equivalent $16.75 General
Category: Neurology
12/11/2024 EMD Serono, Inc. Mavenclad (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,653.00 General
Category: Neurology
12/09/2024 EMD Serono, Inc. Mavenclad (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,463.00 General
Category: Neurology
12/04/2024 EMD Serono, Inc. — Food and Beverage Cash or cash equivalent $58.76 General
11/26/2024 Amgen Inc. UPLIZNA (Biological) Consulting Fee Cash or cash equivalent $2,200.00 General
Category: Inflammation/Rare Disease
11/19/2024 EMD Serono, Inc. Mavenclad (Drug) Travel and Lodging Cash or cash equivalent $397.94 General
Category: Neurology
11/19/2024 EMD Serono, Inc. Mavenclad (Drug) Food and Beverage Cash or cash equivalent $22.59 General
Category: Neurology
11/15/2024 EMD Serono, Inc. — Food and Beverage Cash or cash equivalent $74.35 General
11/07/2024 EMD Serono, Inc. Mavenclad (Drug) Travel and Lodging Cash or cash equivalent $640.96 General
Category: Neurology
11/07/2024 EMD Serono, Inc. Mavenclad (Drug) Travel and Lodging Cash or cash equivalent $375.68 General
Category: Neurology
11/07/2024 EMD Serono, Inc. Mavenclad (Drug) Travel and Lodging Cash or cash equivalent $326.88 General
Category: Neurology
11/06/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Consulting Fee Cash or cash equivalent $2,360.00 General
Category: Rare Disease
10/31/2024 Amgen Inc. UPLIZNA (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,700.00 General
Category: Inflammation/Rare Disease
10/29/2024 GENZYME CORPORATION — Food and Beverage In-kind items and services $84.63 General
10/25/2024 EMD Serono, Inc. — Food and Beverage Cash or cash equivalent $28.54 General
10/24/2024 Genentech USA, Inc. Ocrevus (Biological), Ocrevus Zunovo Food and Beverage In-kind items and services $116.22 General
Category: Immunology
10/24/2024 TG Therapeutics, Inc. BRIUMVI (Drug) Food and Beverage In-kind items and services $93.87 General
Category: Immunology
10/23/2024 EMD Serono, Inc. Mavenclad (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $6,843.00 General
Category: Neurology
10/23/2024 EMD Serono, Inc. — Food and Beverage Cash or cash equivalent $124.27 General
10/22/2024 Amgen Inc. KRYSTEXXA (Biological) Travel and Lodging Cash or cash equivalent $272.95 General
Category: Inflammation/Rare Disease
10/22/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage Cash or cash equivalent $263.45 General
Category: Inflammation/Rare Disease
123…30»

Research Studies & Clinical Trials

Study Name Company Amount Records
TV5600-CNS-20006 Teva Pharmaceuticals USA, Inc. $6,471 2
Efficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS) Biogen, Inc. $1,333 9
Collection of Blood Samples From Patients With Relapsing Forms of Multiple Sclerosis (RMS) Who Have Developed Immune Thrombocytopenic Purpura (ITP) After LEMTRADA Treatment SANOFI US SERVICES INC. $1,152 1

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 13 432 22,001 $406,306 $151,264
2022 15 472 23,446 $428,492 $160,421
2021 10 402 16,329 $297,833 $118,261
2020 13 428 14,040 $275,946 $105,796
Total Patients
1,734
Total Services
75,816
Medicare Billing
$535,742
Procedure Codes
51

All Medicare Procedures & Services

51 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
J0585 Injection, onabotulinumtoxina, 1 unit Office 2023 34 21,510 $279,630 $104,209 37.3%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 74 81 $20,412 $9,789 48.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 80 86 $16,082 $7,047 43.8%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 56 56 $16,296 $6,026 37.0%
64616 Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box Office 2023 11 35 $22,387 $5,003 22.3%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 32 33 $11,847 $4,070 34.4%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 27 27 $9,801 $3,937 40.2%
64644 Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity Office 2023 11 27 $12,663 $3,695 29.2%
95874 Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle Office 2023 20 51 $5,508 $2,924 53.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 30 30 $3,780 $1,788 47.3%
95886 Needle measurement of electrical activity in arm or leg muscles, complete study Office 2023 16 24 $4,032 $1,690 41.9%
92133 Imaging of optic nerve Office 2023 28 28 $2,464 $606.88 24.6%
95819 Measurement of brain wave activity (eeg), awake and asleep Facility 2023 13 13 $1,404 $479.93 34.2%
J0585 Injection, onabotulinumtoxina, 1 unit Office 2022 40 22,920 $297,960 $110,905 37.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 95 100 $18,700 $8,335 44.6%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 63 68 $17,136 $7,899 46.1%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 57 57 $16,587 $7,082 42.7%
64616 Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box Office 2022 11 34 $20,552 $4,616 22.5%
64644 Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity Office 2022 17 32 $15,008 $4,515 30.1%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 32 32 $11,488 $4,378 38.1%
95874 Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle Office 2022 30 62 $6,696 $3,818 57.0%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 16 16 $5,808 $2,530 43.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 30 30 $3,780 $1,489 39.4%
95886 Needle measurement of electrical activity in arm or leg muscles, complete study Office 2022 12 19 $3,192 $1,479 46.3%
64643 Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity Office 2022 11 17 $4,641 $1,198 25.8%
123»

About Dr. Geoffrey Eubank, MD

Dr. Geoffrey Eubank, MD is a Vascular Neurology healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1992799167.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Geoffrey Eubank, MD has received a total of $538,903 in payments from pharmaceutical and medical device companies, with $91,054 received in 2024. These payments were reported across 734 transactions from 23 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($383,414).

As a Medicare-enrolled provider, Eubank has provided services to 1,734 Medicare beneficiaries, totaling 75,816 services with total Medicare billing of $535,742. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.

Practice Information

  • Specialty Vascular Neurology
  • Other Specialties Neurology
  • Location Columbus, OH
  • Active Since 09/02/2005
  • Last Updated 08/02/2024
  • Taxonomy Code 2084V0102X
  • Entity Type Individual
  • NPI Number 1992799167

Products in Payments

  • OCREVUS (Biological) $73,411
  • Mavenclad (Drug) $71,563
  • BRIUMVI (Drug) $48,956
  • AUBAGIO (Drug) $48,199
  • TYSABRI (Biological) $28,084
  • TECFIDERA (Drug) $27,843
  • ZEPOSIA (Drug) $27,053
  • UPLIZNA (Drug) $25,226
  • MAVENCLAD (Drug) $20,827
  • GILENYA (Drug) $20,575
  • VUMERITY (Drug) $16,305
  • LEMTRADA (Drug) $14,342
  • Mavenclad (Biological) $13,491
  • Ocrevus (Biological) $11,729
  • UPLIZNA (Biological) $11,275
  • Non-Covered Product (Drug) $9,358
  • AMPYRA (Drug) $8,467
  • Ozanimod (Drug) $7,031
  • Laquinimod (Drug) $6,471
  • COPAXONE (Drug) $2,925

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Vascular Neurology Doctors in Columbus

Chad Miller, Md, MD

Vascular Neurology — Payments: $51,634

Vascular Neurology $51,634

Dr. James Burke, Md, MD

Vascular Neurology — Payments: $516.47

Vascular Neurology $516.47

Adnan Safdar, Md, MD

Vascular Neurology — Payments: $304.67

Vascular Neurology $304.67

Nikita Dedhia, M.d, M.D

Vascular Neurology — Payments: $216.54

Vascular Neurology $216.54

William Carroll, Md, MD

Vascular Neurology — Payments: $204.77

Vascular Neurology $204.77

Alicia Zha, Md, MD

Vascular Neurology — Payments: $177.29

Vascular Neurology $177.29